Ismail Ali

Ismail Ali, Director of Policy and Advocacy at MAPS, passionately supports psychedelics as promising mental health treatments, particularly for those unresponsive to conventional therapies. In contrast, Kevin Sabet, former White House drug policy advisor, raises alarms about the unknown long-term effects of these substances. They dive into the ethical concerns of legalization, the need for rigorous regulation, and the ongoing debate surrounding the legitimacy of psychedelic research. Tune in for a thought-provoking clash on mental health and psychedelics!

An expert in psychedelics, Ismail Ali, explores the history and potential future of psychedelics in our society. Topics include the current crossroads in the use of psychedelics, the personal journey of Ismail Ali, the flaws in the medical system, the intersection of religious freedom and entheogens, the dark side of psychedelics, and the efforts to legalize and medicalize psychedelics.